Literature DB >> 16481663

Symptoms versus impairment: the case for respecting DSM-IV's Criterion D.

Michael Gordon1, Kevin Antshel, Stephen Faraone, Russell Barkley, Larry Lewandowski, James J Hudziak, Joseph Biederman, Charles Cunningham.   

Abstract

Diagnosing ADHD based primarily on symptom reports assumes that the number/frequency of symptoms is tied closely to the impairment imposed on an individual's functioning. That presumed linkage encourages diagnosis more by Diagnostic and Statistical Manual of Mental Disorders (4th ed.) style symptom lists than well-defined, psychometrically sound assessments of impairment. The current study correlated measures reflecting each construct in four separate, large-scale ADHD research samples. Average correlation between symptoms and impairment accounted for less than 10% of variance. Symptoms never predicted more than 25% of the variance in impairment. When an ADHD group was formed according to a measure of current symptoms, the sample size shrunk by 77% when a criterion-based measure of impairment was added. The partial unlinking of symptoms and impairment has implications for decisions about the diagnostic process, research criteria for participant inclusion, prevalence estimates, gender ratios, evaluation of treatment effects, service delivery, and many other issues.

Entities:  

Mesh:

Year:  2006        PMID: 16481663     DOI: 10.1177/1087054705283881

Source DB:  PubMed          Journal:  J Atten Disord        ISSN: 1087-0547            Impact factor:   3.256


  53 in total

1.  Impact of the impairment criterion in the diagnosis of adult ADHD: 33-year follow-up study of boys with ADHD.

Authors:  Salvatore Mannuzza; Francisco X Castellanos; Erica R Roizen; Jesse A Hutchison; Erin C Lashua; Rachel G Klein
Journal:  J Atten Disord       Date:  2010-04-08       Impact factor: 3.256

2.  Pharmacotherapy for parents with attention-deficit hyperactivity disorder (ADHD): impact on maternal ADHD and parenting.

Authors:  Andrea Chronis-Tuscano; Mark A Stein
Journal:  CNS Drugs       Date:  2012-09-01       Impact factor: 5.749

3.  Diagnosing and managing complicated ADHD.

Authors:  Robert L Findling; L Eugene Arnold; Laurence L Greenhill; Christopher J Kratochvil; James J McGough
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2008

Review 4.  Attention deficit hyperactivity disorder in African American children: what can be concluded from the past ten years?

Authors:  Torri W Miller; Joel T Nigg; Robin L Miller
Journal:  Clin Psychol Rev       Date:  2008-10-11

Review 5.  Functional impairment in Latino children with ADHD: implications for culturally appropriate conceptualization and measurement.

Authors:  Lauren Marie Haack; Alyson C Gerdes
Journal:  Clin Child Fam Psychol Rev       Date:  2011-09

6.  Tracking the Influence of Autistic Traits on Competencies Among School Aged Children with Subthreshold Autistic Traits: A Longitudinal Study.

Authors:  Eileen T Crehan; Julie Baer; Robert R Althoff; John N Constantino
Journal:  Child Psychiatry Hum Dev       Date:  2018-12

7.  Psychometric properties of a modified version of the Weiss Functional Impairment Rating Scale-Parent Report (WFIRS-P) in a clinical sample of children with aggressive behavior.

Authors:  Teresa Kernder; Manfred Doepfner; Christina Dose; Anja Goertz-Dorten
Journal:  Qual Life Res       Date:  2018-10-01       Impact factor: 4.147

8.  The relationship between ADHD symptom dimensions, clinical correlates, and functional impairments.

Authors:  Annie A Garner; Briannon C Oʼconnor; Megan E Narad; Leanne Tamm; John Simon; Jeffery N Epstein
Journal:  J Dev Behav Pediatr       Date:  2013-09       Impact factor: 2.225

9.  Parental Cognitive Errors Mediate Parental Psychopathology and Ratings of Child Inattention.

Authors:  Lauren M Haack; Yuan Jiang; Kevin Delucchi; Nina Kaiser; Keith McBurnett; Stephen Hinshaw; Linda Pfiffner
Journal:  Fam Process       Date:  2016-09-24

Review 10.  Targeting Functional Impairments in the Treatment of Children and Adolescents with ADHD.

Authors:  Tyler Sasser; Erin N Schoenfelder; Mark A Stein
Journal:  CNS Drugs       Date:  2017-02       Impact factor: 5.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.